EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ARID1A and Its Impact Across the Hallmarks of Cancer

Bridger Kearns, Andralyn McKell iD, Isaac Steveson, Peyton Worley, Braeden Barton, Jordan Bennett, DeLaney Anderson, Jacob Harris, James Christensen, Jared J Barrott iD

International Journal of Molecular Sciences · 13.05.2025 · 26 (10) · 4644

DOI: 10.3390/ijms26104644 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.05.2025. Verfasst von Bridger Kearns und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology & Physiology, Brigham Young University, Provo, UT 84602, USA. Hauptthemen laut MEDLINE: Neoplasms, Transcription Factors, DNA-Binding Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ARID1A, a subunit of the SWI/SNF chromatin remodeling complex, has emerged as a pivotal tumor suppressor altered in a broad range of human malignancies. Its frequent inactivation across diverse cancer types has revealed pleiotropic roles that intersect multiple Hallmarks of Cancer. In this review, we integrate current knowledge on how ARID1A loss influences cellular processes including proliferative signaling, resistance to cell death, genomic instability, metabolic reprogramming, immune evasion, and more. We discuss the context-specific consequences of ARID1A deficiency, its cooperation with other oncogenic events, and its implications for therapeutic vulnerability—particularly in the realm of synthetic lethality and immune modulation. By mapping ARID1A’s functional impact onto the established hallmarks framework, we highlight its centrality in cancer biology and underscore opportunities for biomarker-driven strategies and targeted interventions. Understanding ARID1A’s multifaceted roles offers a compelling lens through which to explore chromatin dysregulation in cancer and guide translational advances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsTranscription FactorsDNA-Binding ProteinsHumansAnimalsChromatin Assembly and DisassemblyGenomic InstabilitySignal TransductionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ARID1Adedifferentiationgenomic instabilityimmune evasionproliferationsynthetic lethality

Substanzen

Transcription FactorsARID1A protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Cell Biology & Physiology, Brigham Young University, Provo, UT 84602, USA.
  • Simmons Center for Cancer Research, Brigham Young University, Provo, UT 84602, USA.

ORCID-Profile: Andralyn McKell, Jared J Barrott

Zitieren

APA

Kearns, B., McKell, A., Steveson, I., Worley, P., Barton, B., Bennett, J., Anderson, D., Harris, J., Christensen, J., & Barrott, J. J. (2025). ARID1A and Its Impact Across the Hallmarks of Cancer. International Journal of Molecular Sciences, 26(10), 4644. https://doi.org/10.3390/ijms26104644

Vancouver

Kearns B, McKell A, Steveson I, Worley P, Barton B, Bennett J, et al. ARID1A and Its Impact Across the Hallmarks of Cancer. International Journal of Molecular Sciences. 2025;26(10):4644. doi:10.3390/ijms26104644

BibTeX
@article{Kearns2025,
  author = {Kearns, Bridger and McKell, Andralyn and Steveson, Isaac and Worley, Peyton and Barton, Braeden and Bennett, Jordan and Anderson, DeLaney and Harris, Jacob and Christensen, James and Barrott, Jared J},
  title = {ARID1A and Its Impact Across the Hallmarks of Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {10},
  pages = {4644},
  doi = {10.3390/ijms26104644}
}
Kostenlos starten →